PHASE II STUDY OF DURVALUMAB (ANTI-PD-L1) COMBINED WITH EITHER R-CHOP OR LENALIDOMIDE AND R-CHOP IN PREVIOUSLY UNTREATED, HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA
2017 ◽
Vol 35
◽
pp. 419-420
◽
U. Jaeger
◽
N. Kalakonda
◽
H. Everaus
◽
P. Fustier
◽
J. Jaeger
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 8058-8058
G. Corazzelli
◽
F. Frigeri
◽
M. Arcamone
◽
A. Lucania
◽
G. Capobianco
◽
...
2019 ◽
Vol 37
◽
pp. 433-433
R. Bouabdallah
◽
C. Zemmour
◽
J. Schiano de Collela
◽
B. Slama
◽
J. Bladé
◽
...
2018 ◽
Vol 184
(4)
◽
pp. 647-650
Kathryn E. Hudson
◽
David Rizzieri
◽
Samantha M. Thomas
◽
Thomas W. LeBlanc
◽
Zachary Powell
◽
...
Mu-Chen Zhang
◽
Peng-Peng Xu
◽
Ying Fang
◽
Li Wang
◽
Shu Cheng
◽
...
J Duell
◽
K. J Maddocks
◽
E González‐Barca
◽
W Jurczak
◽
A. M Liberati
◽
...
2019 ◽
Vol 24
(8)
◽
pp. 1035
◽
Ian W. Flinn
◽
Jack Erter
◽
Davey B. Daniel
◽
Joseph R. Mace
◽
Jesus G. Berdeja
2017 ◽
Vol 35
◽
pp. 301-302
F. Lv
◽
Z. Xia
◽
K. Xue
◽
Q. Zhang
◽
D. Ji
◽
...
2019 ◽
Vol 37
◽
pp. 555-556
A.J. Davies
◽
O. Tansley Hancock
◽
T. Cummin
◽
J. Caddy
◽
L. Stanton
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6527-6527
S. Ishikura
◽
K. Tobinai
◽
A. Ohtsu
◽
S. Nakamura
◽
T. Yoshino
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8500-8500
◽
I. N. Micallef
◽
M. J. Maurer
◽
D. A. Nikcevich
◽
M. Cannon
◽
D. F. Moore
◽
...
Close
Export Citation Format
Close
Share Document
Close